NCT03373552View on ClinicalTrials.gov

Genetic Polymorphism Associated With Coronary Heart Disease Susceptibility and Variability of Clopidogrel Response

Active, not recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

August 12, 2015

Primary Completion Date

November 15, 2029

Study Completion Date

December 31, 2029

Conditions
Coronary Disease
Interventions
DIAGNOSTIC_TEST

Platelet function assay

Platelet function assay

Trial Locations (1)

5000

Fattouma Bourguiba Hospital, Monastir

All Listed Sponsors
lead

Hôpital Universitaire Fattouma Bourguiba

OTHER

NCT03373552 - Genetic Polymorphism Associated With Coronary Heart Disease Susceptibility and Variability of Clopidogrel Response | Biotech Hunter | Biotech Hunter